Grifols SA
OTC:GIKLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Grifols SA
OTC:GIKLY
|
ES |
|
S
|
Showa Denko KK
F:SWD
|
JP |
|
M
|
McCormick & Company Inc
F:MCX
|
US |
|
B
|
Baltic Classifieds Group PLC
F:983
|
UK |
|
DENTSPLY SIRONA Inc
F:DY2
|
US |
|
Imperial Brands PLC
F:ITBA
|
UK |
|
Dufry AG
OTC:DFRYF
|
CH |
|
K
|
Koninklijke Philips NV
DUS:PHIA
|
NL |
|
C
|
Chemours Co
F:2CU
|
US |
|
R
|
Reading International Inc
F:46B
|
US |
|
V
|
Vinci SA
XHAM:SQU
|
FR |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
G
|
Getlink SE
OTC:GRPTY
|
FR |
|
Panthera Resources PLC
OTC:PATRF
|
UK |
|
T
|
Takashimaya Co Ltd
XMUN:TKM
|
JP |
|
C
|
CenterPoint Energy Inc
XBER:HOU
|
US |
|
Japan Post Bank Co Ltd
F:5JP0
|
JP |
|
M
|
Montana Aerospace AG
SIX:AERO
|
CH |
Bankruptcy Probability
Grifols SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Grifols SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ES |
|
Grifols SA
MAD:GRF
|
5.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Grifols SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Grifols SA has total debt of 9.1B EUR. This includes both short-term (0 EUR) and long-term (9.1B EUR) debt.
You can find a full breakdown on its Balance Sheet.
